New data published regarding the risk of fetal loss following antimalarial use in pregnancy
Researchers from the US Center for Disease Control and Prevention and the Naval Health Research Centre in San Diego have published an analysis of the fetal loss (spontaneous abortion and stillbirth combined) rates among active duty military women using antimalarial medications during pregnancy. More information can be found here.
Photo by Егор Камелев on Unsplash